Salivary peptide fragments from a leech, a tsetse fly and a rat flea have been combined to create a synthetic protein that clamps onto thrombin, the key enzyme in blood clotting, with remarkable strength. Developed by Richard Payne and Joshua…
Blog
-
Expedia Group B2B Supercharges Partner Growth With New AI-Powered Trip Planner and Multiple APIs
During its EXPLORE Connect B2B event for APAC partners, Expedia Group unveiled a new suite of AI and machine learning-powered tools designed to help partners drive speed, scale and personalization. Highlights include Smart Trip AI™, a new trip…
Continue Reading
-
Identification and characterization of the gene associated with purple flowers
The color of flowers plays a crucial role in ornamental plant breeding, impacting its market value significantly. Orychophragmus…
Continue Reading
-
S&P Global and CME Group Complete Sale of OSTTRA to KKR
NEW YORK, October 10, 2025 — S&P Global (NYSE: SPGI) and CME Group today announced that they have completed the sale of OSTTRA to KKR, a leading global investment firm. The terms of the deal for OSTTRA equaled total enterprise value at $3.1 billion, which will be divided evenly between S&P Global and CME Group pursuant to their 50/50 joint venture.
Established in 2021 as a joint venture between CME Group and S&P Global, OSTTRA serves the global financial ecosystem with a comprehensive suite of critical post-trade offerings across interest rates, FX, credit and equity asset classes. OSTTRA provides end-to-end connectivity and workflow solutions to banks, broker-dealers, asset managers, and other market participants across trade processing, trade lifecycle, and optimization.
Barclays and Davis Polk served as financial and legal advisors, respectively, to S&P Global. Citi and Skadden served as financial and legal advisors, respectively, to CME Group.
About S&P Global
S&P Global (NYSE: SPGI) provides essential intelligence. We enable governments, businesses and individuals with the right data, expertise and connected technology so that they can make decisions with conviction. From helping our customers assess new investments to guiding them through sustainability and energy transition across supply chains, we unlock new opportunities, solve challenges and accelerate progress for the world.We are widely sought after by many of the world’s leading organizations to provide credit ratings, benchmarks, analytics and workflow solutions in the global capital, commodity and automotive markets. With every one of our offerings, we help the world’s leading organizations plan for tomorrow, today.
About CME Group
As the world’s leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world’s leading central counterparty clearing providers, CME Clearing.CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”, “SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.
Media Contacts:
S&P Global
Farhan Husain
farhan.husain@spglobal.comInvestor Relations
mark.grant@spglobal.comCME Group
Laurie Bischel
laurie.bischel@cmegroup.comInvestor Relations
investors@cmegroup.comCME-G
Continue Reading
-
ASUS PSUs go all-in on ATX 3.1 to fuel GeForce RTX 50 Series graphics cards
As graphics cards grow more powerful, the standards that govern how they’re powered evolve. So we’ve upgraded a wide selection of our power supply units to meet the latest ATX 3.1 standard, which ensures stable, efficient power delivery for…
Continue Reading
-
NASA to Pack Astronauts Onto a Chip in The Name of Space Health : ScienceAlert
When NASA launches its next stage in lunar exploration next year, its crew will be literally beside themselves as they swing around the Moon.
On board the Artemis II mission will be several experiments on human health, one featuring tissue…
Continue Reading
-
DG ISPR vows to tighten noose around Khawarij terrorists – RADIO PAKISTAN
- DG ISPR vows to tighten noose around Khawarij terrorists RADIO PAKISTAN
- DG ISPR says Chinese weapon systems performed ‘exceptionally well’ during May conflict with India Dawn
- Failure to enforce National Action Plan is enabling surge in…
Continue Reading
-
Saturn’s moon Mimas may have an ocean — and a future spacecraft could find it
The case for a newborn ocean on Saturn’s moon Mimas continues to build.
Research mapping the thickness of the world’s icy crust not only provides a window for how old an existing ocean might be but also probes where the crust might be at its…
Continue Reading
-
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 October 2025
CVMP opinions on veterinary medicinal products
The Committee adopted by consensus a positive opinion for a marketing authorisation from Zoetis Belgium for Lenivia (izenivetmab), for the reduction of pain associated with osteoarthritis in…
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading